Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.550
+0.020 (1.31%)
Sep 18, 2025, 3:08 PM EDT - Market open
Equillium Market Cap
Equillium has a market cap or net worth of $92.23 million as of September 18, 2025. Its market cap has increased by 143.32% in one year.
Market Cap
92.23M
Enterprise Value
80.40M
1-Year Change
143.32%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $92.23M, a decrease of -60.68%. That is a compound annual growth rate of -12.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 91.04M | 243.43% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | 132.29M | 125.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |